Elevai Labs Inc (NASDAQ:ELAB) currently has a daily average trading volume of 112.81M but it saw 243783985 shares traded in last market. With a market cap of 10.46M USD, the company’s current market price of $0.02 came falling about -5.61 while comparing to the previous closing price of $0.02. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.24 and as low as $0.02. In the recent trading on the day, stock has struck highest price mark of $0.02 while lowest mark touched by it was $0.0209.
Taking a look at 20-day trading activity of Elevai Labs Inc (ELAB) gives us an average price of $0.0387, while its current price level is -99.52% below from 52-week high level whereas it is 25.47% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.0993 while that of 200 days or SMA-200 reads an average of $0.4549. A closer look into the stock’s movement over the week reveals that its volatility is standing at 15.22% during that period while stretching the period over a month that increases to 26.11%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 26.66 which implies that the stock is in oversold territory.
Over the week, ELAB’s stock price is moving -22.90% down while it is -80.04% when we observe its performance for the past one month. Year-to-date it is -98.90% down and over the past year, the stock is showing a downside performance of -99.41%.
The company is expected to be releasing its next quarterly report in December, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Elevai Labs Inc’s total number of outstanding shares is 49.38M with 72.98% of that held by the insiders while 18.20% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -63.92% and return on equity (ROE) at -130.35%. Stock’s beta reads -0.56. Stock has a price to book (P/B) ratio of 0.12 while price to sale or P/S ratio amounts to 4.27. Its return on asset (ROA) is -85.53% on average.
